May 01, 2023
Purification of influenza A virus RNA from cell supernatant to check sequences
- Marta Gaglia1,2,
- lea.gaucherand2,3
- 1UW Madison;
- 2Tufts University;
- 3Université de Strasbourg
Protocol Citation: Marta Gaglia, lea.gaucherand 2023. Purification of influenza A virus RNA from cell supernatant to check sequences. protocols.io https://dx.doi.org/10.17504/protocols.io.36wgqj8wxvk5/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: April 28, 2023
Last Modified: May 01, 2023
Protocol Integer ID: 81166
Funders Acknowledgement:
NIH
Grant ID: R01AI137358
Disclaimer
DISCLAIMER – FOR INFORMATIONAL PURPOSES ONLY; USE AT YOUR OWN RISK
The protocol content here is for informational purposes only and does not constitute legal, medical, clinical, or safety advice, or otherwise; content added to protocols.io is not peer reviewed and may not have undergone a formal approval of any kind. Information presented in this protocol should not substitute for independent professional judgment, advice, diagnosis, or treatment. Any action you take or refrain from taking using or relying upon the information presented here is strictly at your own risk. You agree that neither the Company nor any of the authors, contributors, administrators, or anyone else associated with protocols.io, can be held responsible for your use of the information contained in or linked to this protocol or any of our Sites/Apps and Services.
Abstract
We use this protocol to isolate RNA from influenza A virus-containing cell supernatant and monitor maintenance of sequence insertions or mutations
Materials
Reagents
Ultrapure DNase/RNase free dH2O (Thermofisher – Cat# 10-977-015)
RNA cleanup and concentrator (Zymo Research – Cat# R1015) or RNeasy MinElute Cleanup Kit (Qiagen – Cat# 74204)
QIAamp Viral RNA Mini Kit (Qiagen– Cat# 52904)
RNase-Free DNase Set (Qiagen– Cat# 79254)
100% Ethanol (we use VWR Cat#89125-170, but others will work)
iScript Reverse Transcription Supermix (BioRad - Cat #1708841)
dNTPs (we use Thermofisher – Cat#FERR0181, but others should work) – make a working stock of 25 mM
Taq DNA polymerase with standard Taq buffer (New England Biolabs – Cat#M0273)
Primers that bind on either side of the insertion/deletion/mutation
Equipment
Microcentrifuge
Influenza A virus extraction from cell supernatant using QIAamp Viral RNA Mini Kit
Follow the manufacturer's protocol using a starting cell supernatant volume of 140 µl.
Elute in 60 µl buffer AVE.
DNase treatment using Qiagen RNase-free DNase set:
Make mastermix of DNase and buffer. For each sample:
- 10 µl buffer RDD
- 2.5 µl DNase I
Add to each RNA tube, 27.5 µl H2O , and 12.5 µl DNase master mix.
Incubate at RT for 10min.
Purification of RNA using Zymo RNA clean up and concentrator kit:
Follow the manufacturer's protocol, adding 100 µl RNA binding buffer and 300 µl ethanol as the initial step before transferring to column
Elute in 15 µl water.
Note: Can also use RNeasy MinElute kit, using manufacturer's protocol
Reverse transcription with iScript.
For each sample, mix:
- 1 µl purified RNA
- 3 µl 5x iScript reagent
- 11 µl H2O
(total volume = 15 µl)
Also set up one no-RT reaction, same as above but using the iScript no-RT control reagent instead.
Run RT reaction as per manufacturer's protocol:
- 25°C 5 min
- 46°C 20 min
- 95°C 1 min
Before proceeding to PCR, add 35 µl H2O to each reaction.
PCR with Taq polymerase and primers flanking the insertion/deletion/mutation
Mix 4 µl virus cDNA with 46 µl of PCR mix containing :
- 0.4 µl dNTP (25 mM)
- 5 µl 10x Standard Taq buffer
- 0.25 µl Taq (5 U/ µl)
- 2 µl Forward primer (10 µM)
- 2 µl Reverse primer (10 µM)
- 36.35 µl dH2O
Note: other RT and polymerase reagents should work just as well. A proofreading polymerase may be preferable if checking for point mutations
Analysis of fragments
Run fragments on agarose gel to check that you have obtained the expected sizes. If appropriate, gel purify the product and send for Sanger sequencing.